Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Cardiotoxicity × Atorvastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Waldenstrom Macroglobulinemia 1 Triple Negative Breast Neoplasms 1 Rectal Neoplasms 1 Precancerous Conditions 1 Polycystic Ovary Syndrome 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Prolymphocytic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Neoplasms 1 Inflammatory Breast Neoplasms 1 Hodgkin Disease 1 Hemangioma, Cavernous, Central Nervous System 1 Heart Failure 1 Heart Diseases 1 Erectile Dysfunction 1 Endometriosis 1 Colonic Neoplasms 1 Chromosome 17 deletion 1

Interventions

Exercise 2 Trastuzumab 1 Reverse Transcriptase Polymerase Chain Reaction 1 Paclitaxel 1 Mass Spectrometry 1 Magnetic Resonance Spectroscopy 1 Lisinopril 1 Lapatinib 1 Gene Expression Profiling 1 Fluorophotometry 1 Exercise Test 1 Doxorubicin 1 Cyclophosphamide 1 Chemotherapy, Adjuvant 1 Carvedilol 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02674204 2019-05-15

STOP

Cedars-Sinai Medical Center

Phase 2 Terminated

2 enrolled 7 charts

Breast Neoplasms, Heart Diseases, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡